… Multiple neurotransmitter synthesis by human neuroblastoma … A primate model of
parkinsonism: selective destruction of … to low doses of the parkinsonism-inducing neurotoxin 1-…

… Cultured mesencephalic cells were exposed to drugs for 24 h on 9 days in vitro. The cultures
were incubated in EMEM containing 10% horse serum without drugs for further 48 h and …

… A human neuroblastoma cell line expressing the dopamine transporter (DAT) was utilized
to examine the effects of MPP + on acute physiologic responses and subsequent cell death. …

… of epicatechin and edaravone in combination with levodopa as anti-Parkinson drug (L-Dopa;)
on the proliferation and apoptosis in SH-SY5Y neuroblastoma cell line affected by 6-OH …

… SH-SY5Y human neuroblastoma cells were incubated with 6-hydroxydopamine (6-OHDA)
for 4 and 24 h to examine the mechanism of cell death and to determine the time-dependent …

… se toxic to dopaminergic human neuroblastoma SH-SY5Y cells… of autophagy underlies the
parkinsonism in HD patients. Our … the death of dopaminergic human neuroblastoma SH-SY5Y …

… parkinsonism. However, the mechanisms of these degenerative pathways are not well
understood. To unravel these mechanisms SH-SY5Y neuroblastoma … in human neuroblastoma …

… Rat pheochromocytoma PC-12 cells and dopaminergic human neuroblastoma SH-SY5Y
cells subjected to serum and nerve growth factor withdrawal exhibit death by apoptosis. …

… Antiparkinsonian agents that are direct DA agonists such as apomorphine (Grünblatt et al., …
The human neuroblastoma cell line SH-SY5Y, which was subcloned from the SK-N-SH cell …

… )-B inhibitor antiparkinson drug that exerts neuroprotective … human SH-SY5Y neuroblastoma
and rat PC12 cells.7 Our findings provide evidence, for the first time, that these novel drugs …